These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 17709155)
1. Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. Borroni B; Gardoni F; Parnetti L; Magno L; Malinverno M; Saggese E; Calabresi P; Spillantini MG; Padovani A; Di Luca M Neurobiol Aging; 2009 Jan; 30(1):34-40. PubMed ID: 17709155 [TBL] [Abstract][Full Text] [Related]
2. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445 [TBL] [Abstract][Full Text] [Related]
3. A combination of CSF tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy. Borroni B; Malinverno M; Gardoni F; Grassi M; Parnetti L; Agosti C; Alberici A; Premi E; Bonuccelli U; Gasparotti R; Calabresi P; Di Luca M; Padovani A J Alzheimers Dis; 2010; 22(1):195-203. PubMed ID: 20847421 [TBL] [Abstract][Full Text] [Related]
5. Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration. Noguchi M; Yoshita M; Matsumoto Y; Ono K; Iwasa K; Yamada M J Neurol Sci; 2005 Oct; 237(1-2):61-5. PubMed ID: 15992827 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis of progressive supranuclear palsy: can measurement of tau forms help? Kuiperij HB; Verbeek MM Neurobiol Aging; 2012 Jan; 33(1):204.e17-8. PubMed ID: 20947213 [TBL] [Abstract][Full Text] [Related]
7. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders. Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882 [TBL] [Abstract][Full Text] [Related]
8. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Jellinger KA Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518 [TBL] [Abstract][Full Text] [Related]
9. Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy. Schirinzi T; Sancesario GM; Di Lazzaro G; Scalise S; Colona VL; Imbriani P; Mercuri NB; Bernardini S; Lang AE; Pisani A J Neural Transm (Vienna); 2018 Sep; 125(9):1373-1379. PubMed ID: 29948175 [TBL] [Abstract][Full Text] [Related]